Star Health and Allied Insurance Company Limited (NSE:STARHEALTH)
India · Delayed Price · Currency is INR 487.80
+0.80 (0.16%)
Nov 4, 2025, 1:30 PM IST
NSE:STARHEALTH Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Premiums & Annuity Revenue | 156,171 | 148,222 | 129,383 | 112,616 | 98,092 | 46,266 | Upgrade |
Total Interest & Dividend Income | 9,331 | 9,914 | 9,256 | 8,233 | 6,305 | 4,138 | Upgrade |
Gain (Loss) on Sale of Investments | 2,877 | 2,877 | 1,575 | 112.35 | 1,623 | 99.26 | Upgrade |
Other Revenue | 89.7 | 92.3 | 37.4 | 38.6 | 13.71 | 3.21 | Upgrade |
| 168,468 | 161,105 | 140,251 | 121,000 | 106,034 | 50,506 | Upgrade | |
Revenue Growth (YoY) | 11.25% | 14.87% | 15.91% | 14.12% | 109.94% | 1.48% | Upgrade |
Policy Benefits | 110,013 | 104,194 | 85,940 | 73,204 | 85,400 | 43,695 | Upgrade |
Policy Acquisition & Underwriting Costs | 24,617 | 22,407 | 18,596 | 16,828 | 14,922 | 5,858 | Upgrade |
Selling, General & Administrative | 25,550 | 25,243 | 23,604 | 20,310 | 18,221 | 14,736 | Upgrade |
Provision for Bad Debts | 4.2 | 4.8 | 25.1 | 10.96 | 26.17 | 345.47 | Upgrade |
Other Operating Expenses | 383.9 | -4.4 | -17.7 | -9.44 | - | - | Upgrade |
Total Operating Expenses | 160,668 | 151,846 | 128,157 | 111,850 | 119,323 | 64,648 | Upgrade |
Operating Income | 7,800 | 9,259 | 12,094 | 9,150 | -13,289 | -14,141 | Upgrade |
Interest Expense | -654.2 | -654.2 | -801.4 | -884.19 | -720.06 | -283.66 | Upgrade |
Currency Exchange Gain (Loss) | 14.1 | 8.3 | - | - | - | - | Upgrade |
Other Non Operating Income (Expenses) | 3.5 | 3.5 | -2.4 | 0.41 | 56.72 | -0.6 | Upgrade |
EBT Excluding Unusual Items | 7,164 | 8,616 | 11,290 | 8,267 | -13,953 | -14,426 | Upgrade |
Gain (Loss) on Sale of Assets | -5.8 | -5.8 | -1.8 | -2.47 | -13.63 | -32.35 | Upgrade |
Pretax Income | 7,158 | 8,611 | 11,289 | 8,264 | -13,966 | -14,458 | Upgrade |
Income Tax Expense | 1,827 | 2,152 | 2,838 | 2,078 | -3,560 | -3,601 | Upgrade |
Net Income | 5,331 | 6,459 | 8,450 | 6,186 | -10,407 | -10,857 | Upgrade |
Net Income to Common | 5,331 | 6,459 | 8,450 | 6,186 | -10,407 | -10,857 | Upgrade |
Net Income Growth | -38.16% | -23.57% | 36.60% | - | - | - | Upgrade |
Shares Outstanding (Basic) | 588 | 587 | 583 | 578 | 558 | 499 | Upgrade |
Shares Outstanding (Diluted) | 594 | 595 | 596 | 594 | 558 | 499 | Upgrade |
Shares Change (YoY) | -0.20% | -0.14% | 0.21% | 6.50% | 11.78% | 1.99% | Upgrade |
EPS (Basic) | 9.07 | 11.01 | 14.48 | 10.70 | -18.65 | -21.75 | Upgrade |
EPS (Diluted) | 8.98 | 10.86 | 14.19 | 10.41 | -18.65 | -21.75 | Upgrade |
EPS Growth | -38.05% | -23.47% | 36.31% | - | - | - | Upgrade |
Free Cash Flow | 9,597 | 12,959 | 11,865 | 12,292 | -75.67 | 8,443 | Upgrade |
Free Cash Flow Per Share | 16.16 | 21.79 | 19.92 | 20.68 | -0.14 | 16.91 | Upgrade |
Operating Margin | 4.63% | 5.75% | 8.62% | 7.56% | -12.53% | -28.00% | Upgrade |
Profit Margin | 3.16% | 4.01% | 6.02% | 5.11% | -9.81% | -21.50% | Upgrade |
Free Cash Flow Margin | 5.70% | 8.04% | 8.46% | 10.16% | -0.07% | 16.72% | Upgrade |
EBITDA | 7,972 | 9,569 | 12,681 | 9,671 | -12,856 | -13,684 | Upgrade |
EBITDA Margin | 4.73% | 5.94% | 9.04% | 7.99% | -12.13% | -27.09% | Upgrade |
D&A For EBITDA | 172.05 | 310.4 | 587.1 | 520.67 | 432.99 | 457.3 | Upgrade |
EBIT | 7,800 | 9,259 | 12,094 | 9,150 | -13,289 | -14,141 | Upgrade |
EBIT Margin | 4.63% | 5.75% | 8.62% | 7.56% | -12.53% | -28.00% | Upgrade |
Effective Tax Rate | 25.53% | 24.99% | 25.14% | 25.15% | - | - | Upgrade |
Source: S&P Global Market Intelligence. Insurance template. Financial Sources.